Prescription Drugs Market Size, Share & Industry Analysis, By Product Type (Generics, Orphan, and Other Prescription Drugs), By Therapy (Oncology, Anti-diabetics, Vaccines, Sensory Organs, Immunosuppressants, Anticoagulants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Prescription Drugs Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Prescription Drugs market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Prescription Drugs market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Prescription Drugs Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Prescription Drugs Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Prescription Drugs Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Strong and Diversified Product Portfolio of Novartis and Pfizer, to Help these Companies Retain a Leading Position
The overall competition landscape of prescription drugs market depicts a competition structure where there is a presence of a large number of prominent market players. But, two major companies: Novartis and Pfizer, with their strong and diverse product portfolio, and presence in key therapeutic areas such as oncology and vaccines, are prominent reasons responsible for the dominance of these companies.

Despite that, a number of other prominent players such as Roche, Johnson & Johnson, and Sanofi also have strong market revenue shares in the global market. A number of companies producing generic equivalents of many drugs such as Dr Reddys Laboratories Ltd., and Lupin Pharmaceuticals, Inc. are also expected to launch a number of products in the forecast period. This is projected to positively impact the global market as these companies are expected to gain market share during the forecast period.

LIST OF KEY COMPANIES PROFILED:

  
Novartis AG
  
Pfizer, Inc.
  
F. Hoffmann-La Roche Ltd
  
Sanofi
  
Johnson & Johnson Services, Inc
  
Merck & Co., Inc.
  
AbbVie, Inc.
  
GlaxoSmithKline plc.
  
AstraZeneca
  
CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY)
  
Others

KEY INDUSTRY DEVELOPMENTS:

April 2020 -Lupin Pharmaceuticals, Inc., announced the launch of the generic drug, Mycophenolic acid delayed-release tablets used for the prevention of the organ rejection in kidney transplant patients in the United States.

March 2020 -Dr Reddys Laboratories Ltd. announced the launch of the generic equivalent of Geodon (Ziprasidone Mesylate) injection, a drug used for schizophrenia patients in the United States.

February 2020 -Dr Reddys Laboratories Ltd. announced the launch of the generic equivalent of Vimovo (naproxen and esomeprazole magnesium), a drug used for inflammation in the United States.

REPORT COVERAGE

The prescription drugs market report provides a thorough analysis of the market and focuses on key features such as prevalence of key diseases - by key countries - 2018, pipeline analysis, key industry developments, new product approvals and regulatory scenario - by key regions. Also, the report offers insights into the market trends and highlights key industry developments. In addition to the above-mentioned factors, the report includes numerous factors that have contributed to the growth of the market over the recent years.

Report Scope & Segmentation

 Segmentation

By Product Type

  
Generics
  
Orphan
  
Other Prescription Drugs

By Therapy

  
Oncology
  
Anti-diabetics
  
Vaccines
  
Sensory Organs
  
Immunosuppressants
  
Anticoagulants
  
Others

By Distribution Channel

  
Hospital Pharmacies
  
Retail Pharmacies & Drug Stores
  
Online Pharmacies

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)
  
Latin America (Brazil, Mexico, and the Rest of Latin America)
  
The Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)